|
TNKS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.70879999999674E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73989999999935E-05 |
| Normal-vs-Stage2 |
4.342100E-02 |
| Normal-vs-Stage3 |
1.404620E-03 |
| Normal-vs-Stage4 |
7.757300E-03 |
| Stage1-vs-Stage2 |
3.887600E-01 |
| Stage1-vs-Stage3 |
9.274200E-01 |
| Stage1-vs-Stage4 |
8.063400E-01 |
| Stage2-vs-Stage3 |
4.412800E-01 |
| Stage2-vs-Stage4 |
4.092600E-01 |
| Stage3-vs-Stage4 |
7.456200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21630000000395E-05 |
| Normal-vs-AfricanAmerican |
2.457500E-03 |
| Normal-vs-Asian |
4.112100E-02 |
| Caucasian-vs-AfricanAmerican |
6.607000E-01 |
| Caucasian-vs-Asian |
9.691400E-01 |
| AfricanAmerican-vs-Asian |
9.070600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.47870000003036E-06 |
| Normal-vs-Female |
2.263000E-01 |
| Male-vs-Female |
3.201100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.593700E-04 |
| Normal-vs-Extreme_Weight |
2.48560000026821E-07 |
| Normal-vs-Obese |
9.836300E-03 |
| Normal-vs-Extreme_Obese |
2.995700E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.990600E-01 |
| Normal_Weight-vs-Obese |
2.179400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.246000E-01 |
| Extreme_Weight-vs-Obese |
6.984700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.274600E-01 |
| Obese-vs-Extreme_Obese |
2.448800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.854420E-01 |
| Normal-vs-Age(41-60Yrs) |
5.375800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.83520000002413E-06 |
| Normal-vs-Age(81-100Yrs) |
3.55810000000067E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.939400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.130550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262040E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.696400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.959600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.305600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.95760000000411E-05 |
| Normal-VS-Type2 PRCC |
3.79790000000213E-05 |
| Normal-VS-KIRP CIMP |
8.861400E-01 |
| Normal-VS-Unclassified PRCC |
1.895160E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.849000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.574200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.936000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.584370E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.568500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.968400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46500000020033E-07 |
| Normal-vs-N1 |
4.155700E-02 |
| Normal-vs-N2 |
6.478000E-02 |
| N0-vs-N1 |
2.819500E-02 |
| N0-vs-N2 |
6.464600E-01 |
| N1-vs-N2 |
6.010000E-01 |
|
|
